{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:07:23Z","timestamp":1788361643335,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Science and Technology Major Project of the Ministry of Science and Technology of China","doi-asserted-by":"publisher","award":["2017ZX09301012"],"award-info":[{"award-number":["2017ZX09301012"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012659","name":"Funds for Creative Research Groups of China, National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81421005"],"award-info":[{"award-number":["81421005"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Chinese National Science Foundation","doi-asserted-by":"publisher","award":["81773957"],"award-info":[{"award-number":["81773957"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of China","doi-asserted-by":"publisher","award":["2017ZX09301012-003"],"award-info":[{"award-number":["2017ZX09301012-003"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.phymed.2018.04.031","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T21:38:38Z","timestamp":1523914718000},"page":"161-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Carnosic acid improves diabetic nephropathy by activating Nrf2\/ARE and inhibition of NF-\u03baB pathway"],"prefix":"10.1016","volume":"47","author":[{"given":"Zhisheng","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjun","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2018.04.031_bib0001","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/sj.ki.5001631","article-title":"Group IVA phospholipase A2-mediated production of fibronectin by oxidized LDL in mesangial cells","volume":"70","author":"Akiba","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.phymed.2018.04.031_bib0002","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/01.HYP.0000184250.37607.da","article-title":"Pathways of renal fibrosis and modulation of matrix turnover in experimental hypercholesterolemia","volume":"46","author":"Chade","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.phymed.2018.04.031_bib0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/ki.1997.18","article-title":"Oxidized LDL stimulates the expression of TGF-beta and fibronectin in human glomerular epithelial cells","volume":"51","author":"Ding","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.phymed.2018.04.031_bib0006","first-page":"444","article-title":"The pathogenesis of diabetic nephropathy. Nature clinical practice","volume":"4","author":"Dronavalli","year":"2008","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.phymed.2018.04.031_bib0007","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrneph.2015.110","article-title":"Chronic kidney disease: metformin increases risk of mortality in patients with advanced chronic kidney disease","volume":"11","author":"Edwards","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.phymed.2018.04.031_bib0008","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1681\/ASN.V641170","article-title":"Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity","volume":"6","author":"Ellis","year":"1995","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phymed.2018.04.031_bib0009","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1755-5922.2010.00218.x","article-title":"Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy","volume":"30","author":"Elmarakby","year":"2012","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.phymed.2018.04.031_bib0010","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.bbagrm.2014.06.018","article-title":"Nrf2 ameliorates diabetic nephropathy progression by transcriptional repression of TGFbeta1 through interactions with c-Jun and SP1","volume":"1839","author":"Gao","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phymed.2018.04.031_bib0011","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1517\/14728214.2014.979151","article-title":"Novel effective drugs for diabetic kidney disease? or not?","volume":"19","author":"Gentile","year":"2014","journal-title":"Expert Opin. Emerging Drugs"},{"key":"10.1016\/j.phymed.2018.04.031_bib0012","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/diacare.28.1.164","article-title":"Diabetic nephropathy: diagnosis, prevention, and treatment","volume":"28","author":"Gross","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phymed.2018.04.031_bib0013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4196\/kjpp.2016.20.1.15","article-title":"Carnosic acid protects against acetaminophen-induced hepatotoxicity by potentiating Nrf2-mediated antioxidant capacity in mice","volume":"20","author":"Guo","year":"2016","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.phymed.2018.04.031_bib0014","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1111\/j.1582-4934.2009.00761.x","article-title":"CXCL16 and oxLDL are induced in the onset of diabetic nephropathy","volume":"13","author":"Gutwein","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.phymed.2018.04.031_bib0015","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.ATV.15.5.704","article-title":"Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins","volume":"15","author":"Hammer","year":"1995","journal-title":"Arteriosclerosis Thrombosis Vasc. Biol."},{"key":"10.1016\/j.phymed.2018.04.031_bib0016","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S2213-8587(15)00123-0","article-title":"Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study","volume":"3","author":"Hung","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.phymed.2018.04.031_bib0017","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.phymed.2018.04.031_bib0018","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1046\/j.1523-1755.1999.07109.x","article-title":"Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy","volume":"71","author":"Jandeleit-Dahm","year":"1999","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.phymed.2018.04.031_bib0019","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2337\/db09-1342","article-title":"The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy","volume":"59","author":"Jiang","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.phymed.2018.04.031_bib0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ki.1995.304","article-title":"Human mesangial cell production of monocyte chemoattractant protein-1: modulation by lovastatin","volume":"48","author":"Kim","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.phymed.2018.04.031_bib0021","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/diacare.27.6.1496","article-title":"Lipids and lipoproteins in patients with type 2 diabetes","volume":"27","author":"Krauss","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phymed.2018.04.031_bib0022","first-page":"67","article-title":"Intraglomerular lipid deposition in routine biopsies","volume":"36","author":"Lee","year":"1991","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.phymed.2018.04.031_bib0023","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1271\/bbb.90938","article-title":"Cilostazol ameliorates nephropathy in type 1 diabetic rats involving improvement in oxidative stress and regulation of TGF-Beta and NF-kappaB","volume":"74","author":"Lee","year":"2010","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.phymed.2018.04.031_bib0024","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2147\/IJNRD.S40172","article-title":"Diabetic nephropathy - complications and treatment","volume":"7","author":"Lim","year":"2014","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"10.1016\/j.phymed.2018.04.031_bib0025","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1021\/tx5003063","article-title":"Induction of Pi form of glutathione S-transferase by carnosic acid is mediated through PI3K\/Akt\/NF-kappaB pathway and protects against neurotoxicity","volume":"27","author":"Lin","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.phymed.2018.04.031_bib0026","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.drudis.2014.10.007","article-title":"Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives","volume":"20","author":"Lv","year":"2015","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.phymed.2018.04.031_bib0027","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-beta: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.phymed.2018.04.031_bib0028","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1113\/jphysiol.2014.272328","article-title":"Diabetic kidney disease: from physiology to therapeutics","volume":"592","author":"Mora-Fernandez","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.phymed.2018.04.031_bib0029","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12263-010-0168-8","article-title":"Nrf2 target genes are induced under marginal selenium-deficiency","volume":"5","author":"Muller","year":"2010","journal-title":"Genes Nutr."},{"key":"10.1016\/j.phymed.2018.04.031_bib0030","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1093\/ndt\/gfi155","article-title":"Role of inflammation in diabetic complications","volume":"20","author":"Navarro","year":"2005","journal-title":"Nephrol. Dialysis Transplantation"},{"key":"10.1016\/j.phymed.2018.04.031_bib0031","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2018.04.031_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/781375","article-title":"Syk\/Src pathway-targeted inhibition of skin inflammatory responses by carnosic acid","volume":"2012","author":"Oh","year":"2012","journal-title":"Mediators Inflammation"},{"key":"10.1016\/j.phymed.2018.04.031_bib0033","doi-asserted-by":"crossref","first-page":"F1141","DOI":"10.1152\/ajprenal.00288.2005","article-title":"Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation","volume":"292","author":"Ohga","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.phymed.2018.04.031_bib0003","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tiv.2015.12.005","article-title":"Protective effect of carnosic acid against paraquat-induced redox impairment and mitochondrial dysfunction in SH-SY5Y cells: role for PI3K\/Akt\/Nrf2 pathway","volume":"32","author":"de Oliveira","year":"2016","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.phymed.2018.04.031_bib0004","article-title":"Carnosic acid protects mitochondria of human neuroblastoma SH-SY5Y cells exposed to paraquat through activation of the Nrf2\/HO-1Axis","author":"de Oliveira","year":"2016","journal-title":"Mol. Neurobiol"},{"key":"10.1016\/j.phymed.2018.04.031_bib0034","first-page":"405","article-title":"Action of irbesartan on blood pressure and glucose\/lipid metabolism, in hemodialysis patients with hypertension","volume":"6","author":"Onishi","year":"2013","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.phymed.2018.04.031_bib0035","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(14)62459-4","article-title":"Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis","volume":"385","author":"Palmer","year":"2015","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.phymed.2018.04.031_bib0036","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/sj.ki.5000209","article-title":"PPARalpha agonist fenofibrate improves diabetic nephropathy in db\/db mice","volume":"69","author":"Park","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.phymed.2018.04.031_bib0037","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/diabetes.54.9.2628","article-title":"Characterization of susceptibility of inbred mouse strains to diabetic nephropathy","volume":"54","author":"Qi","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.phymed.2018.04.031_bib0038","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1046\/j.1523-1755.1999.00587.x","article-title":"Human mesangial cells express inducible macrophage scavenger receptor","volume":"56","author":"Ruan","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.phymed.2018.04.031_bib0039","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1046\/j.1523-1755.2001.00025.x","article-title":"Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation","volume":"60","author":"Ruan","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.phymed.2018.04.031_bib0040","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1017\/S1462399409001057","article-title":"Transcription factors in the pathogenesis of diabetic nephropathy","volume":"11","author":"Sanchez","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.phymed.2018.04.031_bib0041","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-4159.2007.05039.x","article-title":"Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1\/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1","volume":"104","author":"Satoh","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phymed.2018.04.031_bib0042","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nrendo.2010.212","article-title":"Oxidative stress in early diabetic nephropathy: fueling the fire","volume":"7","author":"Singh","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.phymed.2018.04.031_bib0043","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.drudis.2013.04.009","article-title":"Molecular understanding of curcumin in diabetic nephropathy","volume":"18","author":"Soetikno","year":"2013","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.phymed.2018.04.031_bib0044","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-kappaB: a key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phymed.2018.04.031_bib0045","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic classification of diabetic nephropathy","volume":"21","author":"Tervaert","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phymed.2018.04.031_bib0046","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/sj.ki.5000180","article-title":"The PPARalpha ligand fenofibrate: meeting multiple targets in diabetic nephropathy","volume":"69","author":"Varghese","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.phymed.2018.04.031_bib0047","doi-asserted-by":"crossref","first-page":"14960","DOI":"10.1073\/pnas.93.25.14960","article-title":"Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene","volume":"93","author":"Venugopal","year":"1996","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phymed.2018.04.031_bib0048","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/CS20120198","article-title":"Inflammation and the pathogenesis of diabetic nephropathy","volume":"124","author":"Wada","year":"2013","journal-title":"Clin. Sci. (London, England: 1979)"},{"key":"10.1016\/j.phymed.2018.04.031_bib0049","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1016\/j.fct.2012.08.057","article-title":"Acute and 30-day oral toxicity studies of administered carnosic acid","volume":"50","author":"Wang","year":"2012","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phymed.2018.04.031_bib0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jff.2017.01.040","article-title":"Carnosic acid alleviates hyperlipidemia and insulin resistance by promoting the degradation of SREBPs via the 26S proteasome","volume":"31","author":"Xie","year":"2017","journal-title":"J. Funct. Food"},{"key":"10.1016\/j.phymed.2018.04.031_bib0051","doi-asserted-by":"crossref","first-page":"12377","DOI":"10.1038\/srep12377","article-title":"Therapeutic potential of digitoflavone on diabetic nephropathy: nuclear factor erythroid 2-related factor 2-dependent anti-oxidant and anti-inflammatory effect","volume":"5","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2018.04.031_bib0052","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.ki.5002296","article-title":"1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells","volume":"72","author":"Zhang","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.phymed.2018.04.031_bib0053","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.2337\/db11-0807","article-title":"Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy","volume":"60","author":"Zheng","year":"2011","journal-title":"Diabetes"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711318301314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711318301314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:15:10Z","timestamp":1760552110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711318301314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":53,"alternative-id":["S0944711318301314"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2018.04.031","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carnosic acid improves diabetic nephropathy by activating Nrf2\/ARE and inhibition of NF-\u03baB pathway","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2018.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}